TOP TIERMARKET NEWSWIRE
News & sentiment

KYMERA THERAPEUTICS (KYMR) — News & AI sentiment

KYMERA THERAPEUTICS (KYMR) news roundup. 5 stories in the past week, 12 over 30 days. Average 30-day sentiment is 54.3/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 16 sales totalling $396.1M — net selling of $396.1M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
5
avg sentiment 50.2/100
30d stories
12
avg sentiment 54.3/100
Insider net (90d)
$396.1M
0 buys · 16 sells
Congress (90d)
0
0 buys · 0 sells

Latest stories on KYMR

1d ago
Guggenheim raises Kymera Therapeutics price target on IRF5 program
Investing.com Analyst Ratings61 · neutralanalyst
2d ago
2d ago
2d ago
3d ago
Jul 12
Jul 12
Jul 7
Jul 7
Jul 3
Kymera: Building Toward A Defining 2H26 Moment
Seeking Alpha63 · neutralanalyst
Jul 3
Jul 3
Why Kymera Therapeutics Stock Popped This Week
The Motley Fool67 · bullishproduct/pr
Jun 26
Jun 25
Jun 25
Jun 25
Jun 25
Jun 25
Jun 25
Jun 25
Jun 24
Jun 24
Jun 24
Jun 12
Jun 11
Open KYMR in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →